We are live on
!
Find out more
Farallon Capital Management Portfolio holdings
AUM
$21.7B
Turnover
63.92%
1-Year Est. Return
79.24%
This Fund
S&P 500
This Quarter
Est. Return
+18.01%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$23.1B
AUM Growth
-$1.32B
(-5.4%)
Cap. Flow
-$121M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
44.45%
Holding
175
New
31
Increased
22
Reduced
37
Closed
21
Avg Time Held Equity + Options
1.8
years
Top 10 Avg Time Held Equity + Options
0.8
years
Top 20 Avg Time Held Equity + Options
0.8
years
Avg Time Held Equity only
1.9
years
Top 10 Avg Time Held Equity only
0.8
years
Top 20 Avg Time Held Equity only
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Electronic Arts
EA
|
+$1.02B |
| 2 |
Exact Sciences
EXAS
|
+$514M |
| 3 |
CyberArk
CYBR
|
+$507M |
| 4 |
Synopsys
SNPS
|
+$444M |
| 5 |
Broadcom
AVGO
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Autodesk
ADSK
|
+$528M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$352M |
| 3 |
TransUnion
TRU
|
+$333M |
| 4 |
Intuit
INTU
|
+$333M |
| 5 |
Kellanova
K
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.06% |
| 2 | Miscellaneous | 18.23% |
| 3 | Technology | 12.67% |
| 4 | Financials | 9.75% |
| 5 | Communication Services | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $2.05B | 8.85% |
3,000,000
-400,000
| -12% | -$270M |
2025 Q3
1 quarter
|
|
2
Revolution Medicines
RVMD
$40.6B
| $1.16B | 5.03% |
14,582,796
-42,896
| -0.3% | -$2.81M |
2021 Q1
19 quarters
|
|
3
Microsoft
MSFT
$4.01T
| $1.07B | 4.63% |
2,214,079
+300,944
| +16% | +$151M |
2013 Q3
49 quarters
|
|
4
Amazon
AMZN
$2.75T
| $1.04B | 4.5% |
4,499,894
+994,194
| +28% | +$227M |
2025 Q2
2 quarters
|
|
|
5
DELISTED
Electronic Arts
EA
| $1.03B | 4.45% |
+5,035,000
| New | +$1.02B |
2025 Q4
0 quarters
|
|
6
Aon
AON
$60.8B
| $941M | 4.07% |
2,665,238
+387,221
| +17% | +$135M |
2024 Q1
7 quarters
|
|
7
Natera
NTRA
$58.3B
| $897M | 3.88% |
3,914,366
-339,086
| -8% | -$70.7M |
2021 Q2
18 quarters
|
|
8
Boston Scientific
BSX
$64B
| $709M | 3.07% |
7,439,564
+2,693,007
| +57% | +$264M |
2020 Q3
21 quarters
|
|
9
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$98.2B
| $690M | 2.98% |
3,600,000
-1,500,000
| -29% | -$285M |
2025 Q2
2 quarters
|
|
10
Exelixis
EXEL
$15.6B
| $689M | 2.98% |
15,709,500
-3,792,000
| -19% | -$157M |
2018 Q3
29 quarters
|
|
11
BridgeBio Pharma
BBIO
$13.1B
| $688M | 2.98% |
8,998,463
+806,463
| +10% | +$52.9M |
2024 Q3
5 quarters
|
|
|
12
DELISTED
Exact Sciences
EXAS
| $650M | 2.82% |
+6,405,000
| New | +$514M |
2025 Q4
0 quarters
|
|
13
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $645M | 2.79% |
8,000,000
-31,000,000
| -79% | -$2.5B |
2025 Q2
2 quarters
|
|
14
Protagonist Therapeutics
PTGX
$8.84B
| $537M | 2.32% |
6,144,006
-52,000
| -0.8% | -$4.26M |
2017 Q4
32 quarters
|
|
15
Wabtec
WAB
$48.6B
| $529M | 2.29% |
2,476,003
+270,905
| +12% | +$55.7M |
2017 Q1
35 quarters
|
|
16
UnitedHealth
UNH
$365B
| $528M | 2.28% |
1,598,906
-287,594
| -15% | -$97.5M |
2023 Q1
11 quarters
|
|
|
17
DELISTED
CyberArk
CYBR
| $470M | 2.03% |
+1,053,040
| New | +$507M |
2025 Q4
0 quarters
|
|
18
Walt Disney
DIS
$191B
| $469M | 2.03% |
4,125,991
-1,072,977
| -21% | -$118M |
2024 Q2
6 quarters
|
|
|
19
Synopsys
SNPS
$89.7B
| $469M | 2.03% |
+999,200
| New | +$444M |
2025 Q4
0 quarters
|
|
20
PUT
Eli Lilly
LLY
$1.12T
| $403M | 1.74% |
375,000
| – | – |
2025 Q3
1 quarter
|
|
|
21
Thermo Fisher Scientific
TMO
$258B
| $368M | 1.59% |
635,685
-622,556
| -49% | -$352M |
2019 Q4
24 quarters
|
|
22
Lantheus
LNTH
$6.53B
| $361M | 1.56% |
5,427,479
+1,950,252
| +56% | +$113M |
2023 Q1
11 quarters
|
|
23
Aramark
ARMK
$14.5B
| $345M | 1.49% |
9,357,046
+360,844
| +4% | +$13.8M |
2020 Q4
20 quarters
|
|
24
Salesforce
CRM
$203B
| $334M | 1.45% |
1,261,177
-1,201,133
| -49% | -$298M |
2019 Q4
24 quarters
|
|
25
Charles Schwab
SCHW
$163B
| $334M | 1.44% |
3,339,657
+88,000
| +3% | +$8.35M |
2024 Q4
4 quarters
|
|
Similar funds
Farallon Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Farallon Capital Management held 175 positions worth $23.1B, down 5.4% from $24.4B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Farallon Capital Management's Q4 2025 filing shows 31 new, 22 increased, 37 reduced and 21 closed positions. Its largest new stake was Electronic Arts: 5,035,000 shares worth $1.03B. The largest sale was Autodesk, an estimated $528M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 33% a quarter earlier, followed by Miscellaneous and Technology.
- Farallon Capital Management's largest Q4 2025 buy was Electronic Arts: 5,035,000 shares worth $1.03B.
- Farallon Capital Management added most to Boston Scientific in Q4 2025, an estimated $264M increase.
- Farallon Capital Management's biggest Q4 2025 reduction was Thermo Fisher Scientific, cutting an estimated $352M.
- Farallon Capital Management fully exited Autodesk in Q4 2025, selling an estimated $528M.
- Farallon Capital Management's ten largest holdings make up 44% of its $23.1B portfolio in Q4 2025.
- Farallon Capital Management opened 31 new positions and closed 21 in Q4 2025.
- Farallon Capital Management's portfolio value fell 5.4% quarter-over-quarter to $23.1B.
Based on Farallon Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.